Directions for research in the post-myocardial infarction patient with left ventricular dysfunction.

[1]  C. Yancy,et al.  Pharmacologic therapies across the continuum of left ventricular dysfunction. , 2008, The American journal of cardiology.

[2]  A. Kadish,et al.  Device therapies in the post-myocardial infarction patient with left ventricular dysfunction. , 2008, The American journal of cardiology.

[3]  P. McCarthy.  Surgical therapies for post-myocardial infarction patients. , 2008, The American journal of cardiology.

[4]  D. Faxon,et al.  Percutaneous coronary intervention for myocardial infarction with left ventricular dysfunction. , 2008, The American journal of cardiology.

[5]  J. Cleland,et al.  Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure , 2007, European journal of heart failure.

[6]  K. Poh,et al.  Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.

[7]  A. Schoenenberger,et al.  Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. , 2007, JAMA.

[8]  T. Münzel,et al.  Targeting heme-oxidized soluble guanylate cyclase: solution for all cardiorenal problems in heart failure? , 2007, Hypertension.

[9]  J. Stasch,et al.  Targeting Heme-Oxidized Soluble Guanylate Cyclase in Experimental Heart Failure , 2007, Hypertension.

[10]  A. Cohen-Solal,et al.  Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. , 2007, Journal of the American College of Cardiology.

[11]  W. Kraus,et al.  Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. , 2007, American heart journal.

[12]  István Préda,et al.  Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselec , 2007, American heart journal.

[13]  Catherine A. Risebro,et al.  Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization , 2007, Nature.

[14]  Nancy M Albert,et al.  Association between performance measures and clinical outcomes for patients hospitalized with heart failure. , 2007, JAMA.

[15]  M. Yacoub,et al.  Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. , 2006, European heart journal.

[16]  J. Cleland,et al.  Clinical trials update from the Heart Failure Society of America meeting: FIX‐CHF‐4, selective cardiac myosin activator and OPT‐CHF , 2006, European journal of heart failure.

[17]  H. Johnsen,et al.  Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial Infarction (STEMMI) Trial , 2006, Circulation.

[18]  B. Lorell,et al.  A Multicenter Randomized Controlled Comparison of Telephonic Disease Management vs. Automated Home Monitoring in Patients Recently Hospitalized with Heart Failure: Span-CHF II Trial , 2005 .

[19]  Salim Yusuf,et al.  Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta‐analysis , 2005, European journal of heart failure.

[20]  Wojciech Zareba,et al.  Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT‐CRT): Design and Clinical Protocol , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[21]  C. Nienaber,et al.  Prevention of Left Ventricular Remodeling With Granulocyte Colony-Stimulating Factor After Acute Myocardial Infarction: Final 1-year Results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE- , 2005, Circulation.

[22]  M. Yacoub,et al.  Myocardial Insulin-Like Growth Factor-I Gene Expression During Recovery From Heart Failure After Combined Left Ventricular Assist Device and Clenbuterol Therapy , 2005, Circulation.

[23]  C. Yancy,et al.  Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. , 2005, Archives of internal medicine.

[24]  A. Rigby,et al.  Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. , 2005, Journal of the American College of Cardiology.

[25]  R. Schmieder,et al.  Aliskiren, a Novel Orally Effective Renin Inhibitor, Provides Dose-Dependent Antihypertensive Efficacy and Placebo-Like Tolerability in Hypertensive Patients , 2005, Circulation.

[26]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[27]  Hyun-Jai Cho,et al.  Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial , 2004, The Lancet.

[28]  A. Stanton,et al.  Blood Pressure Lowering in Essential Hypertension With an Oral Renin Inhibitor, Aliskiren , 2003, Hypertension.

[29]  M. Walsh,et al.  Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. , 2003, American heart journal.

[30]  N. Freemantle,et al.  The heart failure revascularisation trial (HEART): rationale, design and methodology , 2003, European journal of heart failure.

[31]  Christopher M O'Connor,et al.  Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. , 2003, Journal of the American College of Cardiology.

[32]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[33]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[34]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.